Allergy

Immunology

Quality of life may drop for some during oral immunotherapy

(HealthDay)—For patients with food allergy, quality of life (QOL) following oral immunotherapy (OIT) improves for some but deteriorates in others, according to a study published online May 22 in Allergy.

Immunology

Various diagnostic tools available for ocular allergy

(HealthDay)—There are currently various tools available for diagnosing ocular allergy, although several unmet needs remain, according to a position paper published online April 7 in Allergy.

Immunology

Ruling out penicillin allergy by testing inpatients saves money

(HealthDay)—Inpatient penicillin allergy testing is effective for ruling out penicillin allergy, and results in increased prescription of penicillin and cephalosporin, according to a review published online March 29 in ...

Immunology

Phthalate, paraben levels up in children with atopic dermatitis

(HealthDay)—Children aged 4 to 9 years with atopic dermatitis and with frequent use of emollients have increased urinary levels of low-molecular weight (LMW) phthalate metabolites and parabens, according to a study published ...

Immunology

Tolerance develops in NSAID-induced urticaria/angioedema

(HealthDay)—Patients with nonsteroidal anti-inflammatory drug (NSAID)-induced urticaria/angioedema (NIUA) may develop tolerance to NSAIDs over time, according to a study published online Feb. 22 in Allergy.

Immunology

Ivermectin has topical anti-inflammatory properties

(HealthDay)—Ivermectin (IVM) has anti-inflammatory properties that could be beneficial in treatment of T-cell mediated skin inflammatory diseases, according to an experimental study published online Jan. 4 in Allergy.

Immunology

Interface between allergy, oncology explored

(HealthDay)—The interface between allergic responses and oncology is being explored, which may have implications for treatment, according to a European Academy of Allergy and Clinical Immunology position paper published ...

page 8 from 17